Description:
OsteoBalance™ provides a high calcium osteoporosissupport formula with additional nutritional factors thatpromote optimal calcium absorption and retention andenhance healthy bone mineralization.The nutrients found in OsteoBalance™ are derived from thefollowing:
Calcium microcrystalline hydroxyapatite: New Zealand orAustralian pasture-fed, pesticide-free bovine.Vitamin C (as ascorbyl palmitate): corn dextrose fermentationand palm oil.Vitamin D3: cholesterol from wool fat (lanolin)Minerals: naturally derived from limestoneHorsetail extract: Equisetum arvense (stem) (5:1)Sources of the mineral chelates include:Aspartate: derived from soy protein hydrolysisCitrate/Malate: syntheticGlycinate: syntheticPicolinate: synthetic Health Functions:
†Osteoporosis Support Formula: OsteoBalance™ provides1,200 mg of calcium per serving from calciumcitrate/malate and calcium microcrystalline hydoxyapatite(MCHA). This formula also includes a comprehensiveprofile of important bone building nutrients. Calciumcitrate/malate has excellent bioavailability and providedbone mass support for postmenopausal women withlow dietary calcium intake in a two-year, double blindplacebo-controlled trial. In a separate two-year trial,calcium MCHA maintained healthy bone mineral contentin volunteers. One study demonstrated that concomitantsupplementation of the trace minerals zinc, copper,and manganese with calcium citrate/malate helped topromote proper bone metabolism in postmenopausalsubjects. Magnesium supports healthy bone mineraldensity and boron plays an important role in reducingurinary calcium and magnesium excretion. Like boron,vitamin D reduces urinary calcium loss but is also a keynutrient because it enhances calcium absorption.
†Risk factors for osteoporosis include sex, race, age and inadequate calcium intake. Populations at highest risk for osteoporosis include Caucasian, Asian, and postmenopausal women, andelderly women and men. Adequate calcium intake throughout life is linked to a reduced risk of osteoporosis, as calcium helps to optimize peak bone mass during adolescence and earlyadulthood in conjunction with exercise and healthy diet. Calcium intake greater than 2,000 mg per day has no further known benefit to bone health.
*This is a statement of nutritional support. This statement has not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.For educational purposes only. Consult your physician for any health problems.
Ingredients:
Formula (#OB3)
Seven vegetable capsule contains:
calcium (microcrystalline hydroxyapatite) 600 mg,calcium (citrate/malate) 600 mg,Equisetum arvense (horsetail) extract (stem) (5:1) 300 mg,magnesium (aspartate) 115 mg,manganese (aspartate) 10 mg,zinc (picolinate) 30 mg,copper (glycinate) 2.5 mg,boron (glycinate) 2 mg,vitamin C (as ascorbyl palmitate) 102 mg,vitamin D3 400 i.u.
Servings:
Pure Encapsulations recommends per 2-7 capsules perday, in divided doses, with meals or as directed by physician
Caution:
Not to be taken by pregnant or lactating women.Individuals with heart or kidney problems or whoexperience water retention and swelling should avoidproducts containing horsetail extract.
Horsetail should not be taken in conjunction with diureticmedications.
Disclaimer:
The Food and Drug Administration has not evaluated statements contained herein. These products are not intended to diagnose, treat and cure or prevent disease. Always consult with your professional health care provider before changing any medication.
References:
- Stellon A, Davies A, Webb A, Williams R. Microcrystalline hydroxyapatitecompound in prevention of bone loss in corticosteroid-treated patients withchronic active hepatitis. Postgrad Med J 1985 Sep;61(719):791-796.
- Tranquilli AL et al. Calcium, phosphorus and magnesium intakes correlatewith bone mineral content in postmenopausal women. Gynecol Endocrinol1994 Mar;8(1):55-8.
- Nielsen FH, Hunt CD, Mullen LM, Hunt JR. Effect of dietary boron on mineral,estrogen, and testosterone metabolism in postmenopausal women.FASEB J 1987 Nov;1(5):394-397.
- Saltman PD, Strause LG. The role of trace minerals in osteoporosis. J AmColl Nutr 1993 Aug;12(4):384-389
- Tucker KL et al. Potassium, magnesium, and fruit and vegetable intakesare associated with greater bone mineral density in elderly men andwomen. Am J Clin Nutr 1999 Apr;69(4):727-36.
- Ricci TA, Chowdhury HA, Heymsfield SB, Stahl T, Pierson RN Jr, ShapsesSA. Calcium supplementation suppresses bone turnover during weightreduction in postmenopausal women. J Bone Miner Res 1998Jun;13(6):1045-50.
- Healthnotes Clinical Essentials. Copyright 2004. Healthnotes, Inc.
|
